Header cover image
  • Investing Ideas
  • /
  • Hong Kong Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying

Hong Kong Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying

Results

1

0 new

Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.

1 companies

SSY Group

Market Cap: HK$8.8b

An investment holding company, research, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.

2005

HK$2.98

7D

-2.0%

1Y

-36.7%